Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ShangPharma Corp.

www.shangpharma.com

Latest From ShangPharma Corp.

Finance Watch: A Bountiful November Harvest For Venture-Backed Biopharma

Five funds raised more than $1bn to back biotech firms; Arcus leads recent VC rounds with $107m GV-backed Series C; Celgene, Valeant sell notes to retire debt; and Alnylam cashes in on investor goodwill.

Financing Business Strategies

China IPO Roundup: Strong Spring Financings For Pharma And Biotech

China’s healthcare sector was back to actively raising proceeds from the capital markets in March and April, which witnessed more than 20 IPOs in total, with a stream of other listings being planned.

China Financing

Biopharma Quarterly Dealmaking Statistics, Q2 2015

Q2 biopharma financing reached $15.4 billion, a slight increase over the previous quarter; leading the M&A activity was CVS' $11.8 billion buy of Omnicare; and AstraZeneca and Juno were the two most active dealmakers in cancer immunotherapy, a popular therapeutic focus of Q2 alliances.

BioPharmaceutical Deals

Execs On The Move, March 2014

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • ShangPharma Corp.
  • Senior Management
  • Michael Xin Hui, Chmn. & CEO
    William Dai, CFO
    Jennifer He , VP, Fin.
    Yajun Xu, PhD, SVP, Corp. Dev.
    Art Taveras, PhD, Pres. & CSO
  • Contact Info
  • ShangPharma Corp.
    Phone: (86) 21 5132 0088
    998 Halei Rd., Zhangjiang Hi-Tech Park
    Bldg. #5
    Shanghai, 201203
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register